Spineart UK is proud to announce that it is now officially approved on all three National Health Services (NHS) frameworks covering England, Scotland and Wales. The UK Team has celebrated this achievement coupled with the opening of their new commercial base, where an onsite training facilities for Healthcare Professionals, Surgeons and Staff has been opened.
We are looking forward to the future of Spineart UK!
| Date - Category | Illustration | Title | Excerpt |
|---|---|---|---|
|
|
Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...
|
|
|
|
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
|
|
|
|
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
|
The BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels.
Die folgenden Informationen sind nur für medizinische Fachkräfte bestimmt.
Indem Sie klicken, bestätigen Sie, dass Sie eine medizinische Fachkraft sind.
Andernfalls klicken Sie hier, um zur Startseite zurückzukehren